6/10/2020 12:42:57 PM - Perched within close striking distance of its 52-week and all-time highs, quietly consolidating near its 50 DMA line ($82.75). Reported earnings earnings +22% on +19% sales revenues for the Mar '20 quarter. Prior quarterly comparisons were not strong and steady above the +25% minimum guideline (C criteria). Annual earnings (A criteria) growth has been great after a downturn and loss in FY '13. Priced new Public Offerings on 5/22/19, 1/26/17 and 4/07/16.
6/5/2020 1:08:47 PM - Perched within close striking distance of its 52-week and all-time highs after an orderly consolidation above its 50 DMA line. Reported earnings earnings +22% on +19% sales revenues for the Mar '20 quarter. Prior quarterly comparisons were not strong and steady above the +25% minimum guideline (C criteria). Annual earnings (A criteria) growth has been great after a downturn and loss in FY '13. Priced new Public Offerings on 5/22/19, 1/26/17 and 4/07/16.
4/29/2020 12:39:46 PM - Reported earnings earnings +22% on +19% sales revenues for the Mar '20 quarter. Prior quarterly comparisons were not strong and steady above the +25% minimum guideline (C criteria). Annual earnings (A criteria) growth has been great after a downturn and loss in FY '13. Priced new Public Offerings on 5/22/19, 1/26/17 and 4/07/16.
1/29/2020 12:12:51 PM - Consolidating in an orderly fashion near its 200 DMA line. Last noted with caution in the 8/22/19 mid-day report. Priced a new Public Offering on 5/22/19. Reported earnings earnings +15% on +22% sales revenues for the Dec '19 quarter. Prior quarterly comparisons were not strong and steady above the +25% minimum guideline (C criteria). Annual earnings (A criteria) growth has been great after a downturn and loss in FY '13. Completed new Public Offerings on 1/26/17 and 4/07/16.
8/22/2019 1:10:44 PM - Touched another new all-time high today following 4 consecutive gains. Held its ground stubbornly and made gradual progress since a big gap up on 7/31/19. Priced a new Public Offering on 5/22/19. Reported earnings earnings +0% on +16% sales revenues for the Jun '19 quarter. Prior quarterly comparisons were not strong and steady above the +25% minimum guideline (C criteria). Annual earnings (A criteria) growth has been great after a downturn and loss in FY '13. Completed new Public Offerings on 1/26/17 and 4/07/16.
8/21/2019 12:44:45 PM - Hitting new 52-week and all-time highs with today's 4th consecutive gain. Held its ground near prior highs and wedged higher since a big gap up when last noted with caution in the 7/31/19 mid-day report. Priced a new Public Offering on 5/22/19. Reported earnings earnings +0% on +16% sales revenues for the Jun '19 quarter. Prior quarterly comparisons were not strong and steady above the +25% minimum guideline (C criteria). Annual earnings (A criteria) growth has been great after a downturn and loss in FY '13. Completed new Public Offerings on 1/26/17 and 4/07/16.
7/31/2019 1:10:00 PM - Gapped up today hitting new 52-week and all-time highs. Consolidated near its 50 DMA line after pricing a new Public Offering on 5/22/19. Reported earnings earnings +0% on +16% sales revenues for the Jun '19 quarter. Prior quarterly comparisons were not strong and steady above the +25% minimum guideline (C criteria). Annual earnings (A criteria) growth has been great after a downturn and loss in FY '13. Completed new Public Offerings on 1/26/17 and 4/07/16.
5/24/2019 12:52:40 PM - Trading near its 50 DMA line after pricing a new Public Offering this week. Pulled back from its all-time high but it has not formed a sound base after prior mid-day reports repeatedly noted - "Slumping toward prior highs in the $67 area defining support along with its 50 DMA line ($68.31). Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead. Reported earnings earnings +67% on +50% sales revenues for the Mar '19 quarter. Three of the past 4 quarterly comparisons were above the +25% minimum guideline (C criteria), helping it better match the fact-based investment system's fundamental guidelines. Annual earnings (A criteria) growth has been great after a downturn and loss in FY '13. Completed new Public Offerings on 1/26/17 and 4/07/16."
5/23/2019 12:32:23 PM - Gapped down today and undercut its 50 DMA line after pricing a new Public Offering. Pulled back from its all-time high after proposing the new Public Offering, Prior mid-dat reports noted - "Slumping toward prior highs in the $67 area defining support along with its 50 DMA line ($68.31). Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead. Reported earnings earnings +67% on +50% sales revenues for the Mar '19 quarter. Three of the past 4 quarterly comparisons were above the +25% minimum guideline (C criteria), helping it better match the fact-based investment system's fundamental guidelines. Annual earnings (A criteria) growth has been great after a downturn and loss in FY '13. Completed new Public Offerings on 1/26/17 and 4/07/16."
5/21/2019 12:34:25 PM - Pulling back from its all-time high after proposing a new Public Offering, slumping toward prior highs in the $67 area defining support along with its 50 DMA line ($67.88). Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead. Reported earnings earnings +67% on +50% sales revenues for the Mar '19 quarter. Three of the past 4 quarterly comparisons were above the +25% minimum guideline (C criteria), helping it better match the fact-based investment system's fundamental guidelines. Annual earnings (A criteria) growth has been great after a downturn and loss in FY '13. Completed new Public Offerings on 1/26/17 and 4/07/16.
5/2/2019 1:00:52 PM - Pulling back today after hitting new all-time highs with 3 consecutive volume-driven gains. Prior highs in the $67 area define initial support above its 50 DMA line ($65.06). Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead. Reported earnings earnings +67% on +50% sales revenues for the Mar '19 quarter. Three of the past 4 quarterly comparisons were above the +25% minimum guideline (C criteria), helping it better match the fact-based investment system's fundamental guidelines. Annual earnings (A criteria) growth has been great after a downturn and loss in FY '13. Completed new Public Offerings on 1/26/17 and 4/07/16.
4/25/2019 12:48:19 PM - Pulling back today after hitting new all-time highs with 6 consecutive gains. Due to report earnings news 4/30/19. Found support well above its 50 DMA line during the orderly consolidation since noted in the 3/15/19 mid-day report - "Reported earnings +68% on +35% sales revenues for the Dec '18 quarter. Fundamental concerns remain as prior quarterly earnings have not been strong and steady above the +25% minimum guideline (C criteria). Annual earnings (A criteria) growth has been great after a downturn and loss in FY '13. Completed new Public Offerings on 1/26/17 and 4/07/16."
4/23/2019 12:54:32 PM - Gapped up again today hitting another new all-time high with a volume-driven gain. Due to report earnings news 4/30/19. Found support above its 50 DMA line during the orderly consolidation since noted in the 3/15/19 mid-day report - "Reported earnings +68% on +35% sales revenues for the Dec '18 quarter. Fundamental concerns remain as prior quarterly earnings have not been strong and steady above the +25% minimum guideline (C criteria). Annual earnings (A criteria) growth has been great after a downturn and loss in FY '13. Completed new Public Offerings on 1/26/17 and 4/07/16."
4/22/2019 12:33:12 PM - Gapped up today hitting a new all-time high with a volume-driven gain. Due to report earnings news 4/30/19. Found support above its 50 DMA line during the orderly consolidation since noted in the 3/15/19 mid-day report - "Reported earnings +68% on +35% sales revenues for the Dec '18 quarter. Fundamental concerns remain as prior quarterly earnings have not been strong and steady above the +25% minimum guideline (C criteria). Annual earnings (A criteria) growth has been great after a downturn and loss in FY '13. Completed new Public Offerings on 1/26/17 and 4/07/16."
4/16/2019 12:44:19 PM - Perched near its all-time high. Found support above its 50 DMA line during the consolidation since last noted in the 3/15/19 mid-day report - "Reported earnings +68% on +35% sales revenues for the Dec '18 quarter. Fundamental concerns remain as prior quarterly earnings have not been strong and steady above the +25% minimum guideline (C criteria). Annual earnings (A criteria) growth has been great after a downturn and loss in FY '13. Completed new Public Offerings on 1/26/17 and 4/07/16."
3/15/2019 1:07:48 PM - Endured some distributional pressure in recent weeks while retreating from its all-time high. Last noted in the 1/31/19 mid-day report - "Reported earnings +68% on +35% sales revenues for the Dec '18 quarter. Fundamental concerns remain as prior quarterly earnings have not been strong and steady above the +25% minimum guideline (C criteria). Annual earnings (A criteria) growth has been great after a downturn and loss in FY '13. Completed new Public Offerings on 1/26/17 and 4/07/16."
1/31/2019 12:59:29 PM - Gapped up on the prior session hitting a new all-time high with a considerable volume-driven gain. Reported earnings +68% on +35% sales revenues for the Dec '18 quarter. Fundamental concerns remain as prior quarterly earnings have not been strong and steady above the +25% minimum guideline (C criteria). Annual earnings (A criteria) growth has been great after a downturn and loss in FY '13. Completed new Public Offerings on 1/26/17 and 4/07/16.
1/30/2019 2:12:05 PM - Gapped up today hitting a new all-time high with a considerable volume-driven gain. Reported earnings +68% on +35% sales revenues for the Dec '18 quarter. Fundamental concerns remain as prior quarterly earnings have not been strong and steady above the +25% minimum guideline (C criteria). Annual earnings (A criteria) growth has been great after a downturn and loss in FY '13. Completed new Public Offerings on 1/26/17 and 4/07/16.
8/2/2018 1:37:37 PM - Rebounded from below its 200 DMA line with a big volume-driven gain on the prior session. Reported earnings +47% on +32% sales revenues for the Jun '18 quarter. Prior quarterly earnings (C criteria) have not been strong and steady above the +25% minimum guideline. Annual earnings (A criteria) growth has been great after a downturn and loss in FY '13. Completed new Public Offerings on 1/26/17 and 4/07/16.
12/18/2017 12:49:40 PM - Hit a new 52-week high with above average volume behind today's 4th consecutive gain. Rebounded from below its 50 DMA line ($51.07). Reported earnings +68% on +21% sales revenues for the Sep '17 quarter. Prior quarterly earnings (C criteria) have not been strong and steady above the +25% minimum guideline. Annual earnings (A criteria) growth has been great after a downturn and loss in FY '13. Completed new Public Offerings on 1/26/17 and 4/07/16.
8/2/2017 12:33:53 PM - Undercut its 50 DMA line ($41.39), retreating from its 52-week high. Completed another new Public Offering on 1/26/17. Reported earnings +10% on +35% sales revenues for the Jun '17 quarter. Prior quarterly and annual earnings (A criteria) have been erratic and below guidelines, leaving fundamental concerns. Completed an earlier Public Offering on 4/07/16.
4/26/2017 1:15:42 PM - Undercut its 50 DMA line ($38.40), retreating from its 52-week high. Completed another new Public Offering on 1/26/17. Reported earnings +16% on +63% sales revenues for the Mar '17 quarter. Prior quarterly and annual earnings (A criteria) have been erratic and below guidelines, leaving fundamental concerns. Completed an earlier Public Offering on 4/07/16.
3/27/2017 12:20:49 PM - Pulling back near its 50 DMA line ($36.10), retreating from its 52-week high. Completed another new Public Offering on 1/26/17. Reported earnings +30% on +62% sales revenues for the Dec '16 quarter. Prior quarterly and annual earnings (A criteria) have been erratic and below guidelines, leaving fundamental concerns. Completed an earlier Public Offering on 4/07/16.
1/30/2017 12:32:33 PM - Perched at its 52-week high after completing another new Public Offering on 1/26/17. Gapped up on 1/24/17 rising from an orderly base near its 50 DMA line. Reported earnings +30% on +62% sales revenues for the Dec '16 quarter. Prior quarterly and annual earnings (A criteria) have been erratic and below guidelines, leaving fundamental concerns. Completed an earlier Public Offering on 4/07/16.
1/27/2017 11:47:37 AM - Perched at its 52-week high following volume-driven gains, it gapped up on 1/24/17 rising from an orderly base near its 50 DMA line. Reported earnings +30% on +62% sales revenues for the Dec '16 quarter. Prior quarterly and annual earnings (A criteria) have been erratic and below guidelines, leaving fundamental concerns. It completed a new Public Offering on 4/07/16.
2/14/2011 1:02:11 PM - Quarterly and annual earnings (A criteria) have been erratic and below guidelines, leaving fundamental concerns. It completed a new Public Offering on 2/11/11. Perched only -5.3% off its 52-week high today, building on an orderly base near its 50 DMA line.
1/26/2011 1:39:51 PM - Quarterly and annual earnings (A criteria) have been erratic and below guidelines, leaving fundamental concerns. Gapped up and hit a new 52-week high today after an orderly base above its 50 DMA line.
12/1/2010 2:57:52 PM - Quarterly and annual earnings (A criteria) have been erratic and below guidelines, leaving fundamental concerns. Hit a new 52-week high today with a 5th consecutive gain, getting very extended from the "orderly base" previously noted when it appeared in the 11/11/10 mid-day report.
11/11/2010 12:44:42 PM - Quarterly and annual earnings (A criteria) have been erratic and below guidelines, leaving fundamental concerns. Hit a new 52-week high today following a brief consolidation above prior highs since its 10/29/10 breakout from an orderly base.
1/27/2010 12:59:22 PM - Annual earnings (A criteria) have been below guidelines and the lack of sales revenues growth is another fundamental concern. Spiked to another new 52-week high today following the tight consolidation since its 1/19/10 breakout from an orderly base.